Global Antiepileptic Drugs (AED) Market 2020 Industry Outlook

The global antiepileptic drugs (AED) market size is set to gain traction from the ever-increasing initiatives by manufacturers for producing novel and generic drugs for patients. Patents of numerous second generation drugs are on the verge of expiration. It is thus, opening door to new opportunities and upsurging competition amongst key players. It is likely to affect the market positively in the coming years. This information is provided by Fortune Business Insights™ in a recently published report, titled, “Antiepileptic Drugs (AED) Market Size, Share & Industry Analysis, By Drug Generation (First Generation, Second Generation, and Third Generation), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2019-2026.” The report further mentions that the AED market size stood at USD 16.56 billion in 2018 and is projected to reach USD 20.33 billion by 2026, exhibiting a CAGR of 2.4% during the forecast period.

Click here to get the short-term and long-term impact of COVID-19 on this Antiepileptic Drugs (AED) Market.

Please visit: https://www.fortunebusinessinsights.com/industry-reports/antiepileptic-drug-market-101189

Detailed Table of Content:

1. Introduction

1.1. Research Scope

1.2. Market Segmentation

1.3. Research Methodology

1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities

4. Key Insights

4.1. New Product Launch

4.2. Pipeline Analysis

4.3. Overview of Challenges Faced in the Antiepileptic Drugs Market

4.4. Prevalence of Epilepsy - By Key Countries, 2018

4.5. Key Industry Developments - Mergers, Acquisitions, and Partnerships

5. Global Antiepileptic Drugs Market Analysis, Insights and Forecast, 2015-2026

5.1. Key Findings / Summary

5.2. Market Analysis, Insights and Forecast – By Drug Generation

5.2.1. First Generation

5.2.2. Second Generation

5.2.3. Third Generation

5.3. Market Analysis, Insights and Forecast – By Distribution Channel

5.3.1. Hospital Pharmacies

5.3.2. Retail Pharmacies

5.3.3. Online Pharmacies

5.4. Market Analysis, Insights and Forecast – By Geography

5.4.1. North America

5.4.2. Europe

5.4.3. Asia pacific

5.4.4. Latin America

5.4.5. Middle East & Africa

6. North America Antiepileptic Drugs Market Analysis, Insights and Forecast, 2015-2026

6.1. Key Findings / Summary

6.2. Market Analysis, Insights and Forecast – By Drug Generation

6.2.1. First Generation

6.2.2. Second Generation

6.2.3. Third Generation

6.3. Market Analysis, Insights and Forecast – By Distribution Channel

6.3.1. Hospital Pharmacies

6.3.2. Retail Pharmacies

6.3.3. Online Pharmacies

6.4. Market Analysis, Insights and Forecast – By Country

6.4.1. U.S.

6.4.2. Canada

7. Europe Antiepileptic Drugs Market Analysis, Insights and Forecast, 2015-2026

7.1. Key Findings / Summary

7.2. Market Analysis, Insights and Forecast – By Drug Generation

7.2.1. First Generation

7.2.2. Second Generation

7.2.3. Third Generation

7.3. Market Analysis, Insights and Forecast – By Distribution Channel

7.3.1. Hospital Pharmacies

7.3.2. Retail Pharmacies

7.3.3. Online Pharmacies

7.4. Market Analysis, Insights and Forecast – By Country/Sub-region

7.4.1. U.K.

7.4.2. Germany

7.4.3. France

7.4.4. Spain

7.4.5. Italy

7.4.6. Scandinavia

7.4.7. Rest of Europe

8. Asia Pacific Antiepileptic Drugs Market Analysis, Insights and Forecast, 2015-2026

8.1. Key Findings / Summary

8.2. Market Analysis, Insights and Forecast – By Drug Generation

8.2.1. First Generation

8.2.2. Second Generation

8.2.3. Third Generation

8.3. Market Analysis, Insights and Forecast – By Distribution Channel

8.3.1. Hospital Pharmacies

8.3.2. Retail Pharmacies

8.3.3. Online Pharmacies

8.4. Market Analysis, Insights and Forecast – By Country/Sub-region

8.4.1. Japan

8.4.2. China

8.4.3. India

8.4.4. Australia

8.4.5. Southeast Asia

8.4.6. Rest of Asia Pacific